Background Bone metastases are a significant and undertreated clinical problem in patients
with advanced lung cancer. Design We reviewed the incidence of bone metastases and …

Depression and Survival in Metastatic Non–Small-Cell Lung Cancer: Effects of Early
Palliative Care - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Recent clinical successes of small-molecule epidermal growth factor receptor (EGFR)
inhibitors in treating advanced non–small cell lung cancer (NSCLC) have raised hopes that …

Introduction Bone metastases from non-small cell lung cancer (NSCLC) are associated with
skeletal-related events (SREs) and elevated levels of N-telopeptide of type I collagen (NTX) …

INTRODUCTION: Miliary brain metastasis is a rarity and refers to the presence of numerous
small tumors in a perivascular distribution without intraparenchymal invasion and focal …

Purpose: Epidermal growth factor (EGF) might be a suitable immunotherapeutic target in
non–small-cell lung cancer (NSCLC). Our approach consists of active immunotherapy with …

Purpose: The main goal of this study was to provide the “proof-of-principle” that low-dose
paclitaxel is able to change the tumor microenvironment and improve the outcome of …

Administration of mountain ginseng (MG) extract can restore advanced cancer to a normal
state. To elucidate the mechanism by which MG extract prevents the progression of lung …

Abstract Wingless-type protein (Wnt)/β-catenin pathway alterations in non-small cell lung
cancer (NSCLC) are associated with poor prognosis and resistance. In 598 stage III–IV …

This study aimed to determine the relationship between the endogenous levels of P-
glycoprotein (P-gp), multidrug resistance-associated protein (MRP), lung resistance-related …